Date：23 July (Friday)
Time: 15:40 – 17:10 (GMT+8)
Executive Assistant to the President of Osaka University (2019-)
Professor, Osaka University (2015-)
Visiting Professor, Kobe University (2015-)
Visiting Professor, Tokushima University (2015-2021)
Professor, the University of Tokushima (2010- 2015)
Associate Professor, Osaka University (2005-2010)
Visiting Scientist, University of Rochester (NY) (1998-1999).
Assistant Professor, Osaka University (1992-2005).
Ph.D.(Engineering), Osaka University (1992).
President of Japanese Association of Animal Cell Technology (JAACT)
AFOB, Deputy Secretary Generals (DSGs) and Advisory Board Member, JAPAN
Executive board member and head of KANSAI branch of the Society for Biotechnology, JAPAN
Vice President in Bioengineering division of the Japan Bioindustry Association
The Manufacturing Technology Association of Biologics (MAB) developed integrated technology platforms for the biologics production. Technology Association is non-profit mutual benefit organization (cooperation) and this association focused on manufacturing of biologics including therapeutic antibody, recombinant protein, and gene therapy. In this presentation, we will introduce the research and developments under AMED (Japan Agency for Medical Research and Development) project in manufacturing technologies for therapeutic protein and gene therapy and discuss about next-generation manufacturing platform in biologics production. In this presentation, I would like to introduce the activity of MAB and bio-eco system for biologics manufacturing in Japan.